Evolving Impact of COVID-19 on Transplant Center Practices and Policies in the United States
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd..
In our first survey of transplant centers in March 2020, >75% of kidney and liver programs were either suspended or operating under restrictions. To safely resume transplantation, we must understand the evolving impact of COVID-19 on transplant recipients and center-level practices. We therefore conducted a six-week follow-up survey May 7-15, 2020, and linked responses to the COVID-19 incidence map, with a response rate of 84%. Suspension of live donor transplantation decreased from 72% in March to 30% in May for kidneys and from 68% to 52% for livers. Restrictions/suspension of deceased donor transplantation decreased from 84% to 58% for kidneys and from 73% to 42% for livers. Resuming transplantation at normal capacity was envisioned by 83% of programs by August 2020. Exclusively using local recovery teams for deceased donor procurement was reported by 28%. Respondents reported caring for a total of 1166 COVID-19-positive transplant recipients; 25% were critically ill. Telemedicine challenges were reported by 81%. There was a lack of consensus regarding management of potential living donors or candidates with SARS-CoV-2. Our findings demonstrate persistent heterogeneity in center-level response to COVID-19 even as transplant activity resumes, making ongoing national data collection and real-time analysis critical to inform best practices.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:34 |
|---|---|
| Enthalten in: |
Clinical transplantation - 34(2020), 12 vom: 12. Dez., Seite e14086 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Boyarsky, Brian J [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Clinical decision-making |
|---|
| Anmerkungen: |
Date Completed 04.01.2021 Date Revised 04.01.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/ctr.14086 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM314908994 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM314908994 | ||
| 003 | DE-627 | ||
| 005 | 20231225153746.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/ctr.14086 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1049.xml |
| 035 | |a (DE-627)NLM314908994 | ||
| 035 | |a (NLM)32918766 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Boyarsky, Brian J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Evolving Impact of COVID-19 on Transplant Center Practices and Policies in the United States |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.01.2021 | ||
| 500 | |a Date Revised 04.01.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. | ||
| 520 | |a In our first survey of transplant centers in March 2020, >75% of kidney and liver programs were either suspended or operating under restrictions. To safely resume transplantation, we must understand the evolving impact of COVID-19 on transplant recipients and center-level practices. We therefore conducted a six-week follow-up survey May 7-15, 2020, and linked responses to the COVID-19 incidence map, with a response rate of 84%. Suspension of live donor transplantation decreased from 72% in March to 30% in May for kidneys and from 68% to 52% for livers. Restrictions/suspension of deceased donor transplantation decreased from 84% to 58% for kidneys and from 73% to 42% for livers. Resuming transplantation at normal capacity was envisioned by 83% of programs by August 2020. Exclusively using local recovery teams for deceased donor procurement was reported by 28%. Respondents reported caring for a total of 1166 COVID-19-positive transplant recipients; 25% were critically ill. Telemedicine challenges were reported by 81%. There was a lack of consensus regarding management of potential living donors or candidates with SARS-CoV-2. Our findings demonstrate persistent heterogeneity in center-level response to COVID-19 even as transplant activity resumes, making ongoing national data collection and real-time analysis critical to inform best practices | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, N.I.H., Intramural | |
| 650 | 4 | |a clinical decision-making | |
| 650 | 4 | |a epidemiology | |
| 650 | 4 | |a guidelines | |
| 650 | 4 | |a infectious agents-viral | |
| 700 | 1 | |a Ruck, Jessica M |e verfasserin |4 aut | |
| 700 | 1 | |a Chiang, Teresa Po-Yu |e verfasserin |4 aut | |
| 700 | 1 | |a Werbel, William A |e verfasserin |4 aut | |
| 700 | 1 | |a Strauss, Alexandra T |e verfasserin |4 aut | |
| 700 | 1 | |a Getsin, Samantha N |e verfasserin |4 aut | |
| 700 | 1 | |a Jackson, Kyle R |e verfasserin |4 aut | |
| 700 | 1 | |a Kernodle, Amber B |e verfasserin |4 aut | |
| 700 | 1 | |a Van Pilsum Rasmussen, Sarah E |e verfasserin |4 aut | |
| 700 | 1 | |a Baker, Talia B |e verfasserin |4 aut | |
| 700 | 1 | |a Al Ammary, Fawaz |e verfasserin |4 aut | |
| 700 | 1 | |a Durand, Christine M |e verfasserin |4 aut | |
| 700 | 1 | |a Avery, Robin K |e verfasserin |4 aut | |
| 700 | 1 | |a Massie, Allan B |e verfasserin |4 aut | |
| 700 | 1 | |a Segev, Dorry L |e verfasserin |4 aut | |
| 700 | 1 | |a Garonzik-Wang, Jacqueline M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical transplantation |d 1987 |g 34(2020), 12 vom: 12. Dez., Seite e14086 |w (DE-627)NLM07493306X |x 1399-0012 |7 nnns |
| 773 | 1 | 8 | |g volume:34 |g year:2020 |g number:12 |g day:12 |g month:12 |g pages:e14086 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/ctr.14086 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 34 |j 2020 |e 12 |b 12 |c 12 |h e14086 | ||